These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29956552)

  • 1. PAIN(S) relievers for medicinal chemists: how computational methods can assist in hit evaluation.
    Stork C; Kirchmair J
    Future Med Chem; 2018 Jul; 10(13):1533-1535. PubMed ID: 29956552
    [No Abstract]   [Full Text] [Related]  

  • 2. Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters.
    Stork C; Chen Y; Šícho M; Kirchmair J
    J Chem Inf Model; 2019 Mar; 59(3):1030-1043. PubMed ID: 30624935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hit Dexter: A Machine-Learning Model for the Prediction of Frequent Hitters.
    Stork C; Wagner J; Friedrich NO; de Bruyn Kops C; Šícho M; Kirchmair J
    ChemMedChem; 2018 Mar; 13(6):564-571. PubMed ID: 29285887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Small-Molecule Reactivity Identifies Promiscuous Bioactive Compounds.
    Matlock MK; Hughes TB; Dahlin JL; Swamidass SJ
    J Chem Inf Model; 2018 Aug; 58(8):1483-1500. PubMed ID: 29990427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hit-to-Lead: Hit Validation and Assessment.
    Hevener KE; Pesavento R; Ren J; Lee H; Ratia K; Johnson ME
    Methods Enzymol; 2018; 610():265-309. PubMed ID: 30390802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening Library Design.
    Ashenden SK
    Methods Enzymol; 2018; 610():73-96. PubMed ID: 30390806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery.
    Shi S; Fu L; Yi J; Yang Z; Zhang X; Deng Y; Wang W; Wu C; Zhao W; Hou T; Zeng X; Lyu A; Cao D
    Nucleic Acids Res; 2024 Jul; 52(W1):W439-W449. PubMed ID: 38783035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemical screening in zebrafish for novel biological and therapeutic discovery.
    Wiley DS; Redfield SE; Zon LI
    Methods Cell Biol; 2017; 138():651-679. PubMed ID: 28129862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
    Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
    SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Array-Based Ligand Discovery Platform for Proteins With Short Half-Lives.
    Leifer BS; Doyle SK; Richters A; Evans HL; Koehler AN
    Methods Enzymol; 2018; 610():191-218. PubMed ID: 30390799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Big pharma screening collections: more of the same or unique libraries? The AstraZeneca-Bayer Pharma AG case.
    Kogej T; Blomberg N; Greasley PJ; Mundt S; Vainio MJ; Schamberger J; Schmidt G; Hüser J
    Drug Discov Today; 2013 Oct; 18(19-20):1014-24. PubMed ID: 23127858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection.
    Chakravorty SJ; Chan J; Greenwood MN; Popa-Burke I; Remlinger KS; Pickett SD; Green DVS; Fillmore MC; Dean TW; Luengo JI; Macarrón R
    SLAS Discov; 2018 Jul; 23(6):532-545. PubMed ID: 29699447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: recent trends in library design and virtual screening in medicinal chemistry and drug discovery.
    Kumar BV; Sriram D; Yogeeswari P
    Curr Top Med Chem; 2014; 14(16):1865. PubMed ID: 25262807
    [No Abstract]   [Full Text] [Related]  

  • 15. Frequent hitters: nuisance artifacts in high-throughput screening.
    Yang ZY; He JH; Lu AP; Hou TJ; Cao DS
    Drug Discov Today; 2020 Apr; 25(4):657-667. PubMed ID: 31987936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Accurate Filters to Flag Frequent Hitters in AlphaScreen Assays by Suggesting their Mechanism.
    Ghosh D; Koch U; Hadian K; Sattler M; Tetko IV
    Mol Inform; 2022 Mar; 41(3):e2100151. PubMed ID: 34676998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmaceutical Machine Learning: Virtual High-Throughput Screens Identifying Promising and Economical Small Molecule Inhibitors of Complement Factor C1s.
    Chen JJ; Schmucker LN; Visco DP
    Biomolecules; 2018 May; 8(2):. PubMed ID: 29735903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.
    Kauler KR; Hevener KE
    Methods Mol Biol; 2025; 2834():181-193. PubMed ID: 39312166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integration of RNAi and Small Molecule Screens to Identify Targets for Drug Development.
    Drosopoulos K; Linardopoulos S
    Methods Mol Biol; 2019; 1953():33-42. PubMed ID: 30912014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hit triage using efficiency indices after screening of compound libraries in drug discovery.
    Reitz AB; Smith GR; Tounge BA; Reynolds CH
    Curr Top Med Chem; 2009; 9(18):1718-24. PubMed ID: 19929837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.